Aktienanalyse zu AdvanSix Inc. (ASIX)ASIXAdvanSix Inc.

AdvanSix Inc. is a vertically integrated chemistry company that produces essential materials for diverse end markets across building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives, electronics and other end markets. Its product lines include nylon solutions, plant nutrients, and chemical intermediates. It sells its Nylon 6 resin, under the Aegis brand name. It also markets and sells Caprolactam to manufacture polymer resins to produce fibers, compounds and other nylon products. It markets and sells ammonium sulfate to North American and South American distributors, farm cooperatives and retailers to fertilize crops. It manufactures sulfuric acid, ammonia and carbon dioxide. Its other intermediate chemicals include phenol, alpha-methyl styrene, cyclohexanone, oximes, cyclohexanol, and alkyl and specialty amines. Its end-products for intermediates include automotive components and water treatment and pharmaceutical intermediates. It operates in the Basic Materials sector (PLASTIC MATERIALS, SYNTH RESINS & NONVULCAN ELASTO industry).

AdvanSix Inc (ASIX) is currently not a strong buy. The stock is priced at $16.37, with a recent RSI of 47.68 indicating a neutral momentum. The forward P/E ratio is 0, suggesting uncertainty in future earnings, while the gross margin has decreased to 7.38% in Q2 2026, down from 14.32% in Q2 2025. The recent performance shows a year-to-date decline of 4.94% and a one-year change of -14.43%, indicating a lack of upward momentum. The main risk is the negative net income reported in Q1 2026 at -$15.5 million, which raises concerns about profitability moving forward.

2 analysts cover ASIX: 2 rate it Buy, 0 Hold and 0 Sell. The average price target is 19.00.